Peer-reviewedCC BY 4.0Cancers26 Oct 2026

Interpreting the Early Cancer Peak in Immune-Mediated Inflammatory Diseases. Comment on Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 1027

Alper Gumustepe¹
Esra Gumustepe²

¹Department of Rheumatology, Atatürk Sanatorium Training and Research Hospital, Ankara 06290, Türkiye
²Department of Radiation Oncology, Ankara University Faculty of Medicine, Ankara, 06620 Türkiye

Reply to Gumustepe, A.; Gumustepe, E. Comment on “Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 3449”
Barbara Giordani, Luigi Pirtoli, Guido Putignano +3
Cancers2 Nov 2026Peer-reviewedCC BY 4.0OncologyCrossref
COVID-19 severity and early inflammatory biomarkers in patients with immune-mediated inflammatory rheumatic diseases: a multicenter cohort study
Andreea-Iulia Vlădulescu-Trandafir, Gelu Onose, Violeta-Claudia Bojincă +5
Journal of medicine and life1 Aug 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Evolution of direct and indirect costs of chronic systemic auto-immune and inflammatory rheumatic diseases in France: a 2015–2023 nationwide population-based study
Laurent Arnaud, Thierry Martin, François Chasset +1
RMD Open8 Nov 2026Peer-reviewedCC BYFull textGeneral medicineDOAJ
Chinese expert consensus on the treatment of immune‑mediated inflammatory diseases with Janus kinase inhibitors.
Xiaofeng Zeng, Jianzhong Zhang, Minhu Chen +1
Rheumatology and immunology research22 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis on longitudinal patient data
Sergio H. Martínez-Mateu, Yolanda Guillén, Edgar Angelats +23
Cell Reports Medicine11 Sep 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMC

Cite

BibTeX

@article{gumustepe2026interpreting,
  title = {{Interpreting the Early Cancer Peak in Immune-Mediated Inflammatory Diseases. Comment on Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 1027}},
  author = {Alper Gumustepe and Esra Gumustepe},
  journal = {Cancers},
  year = {2026},
  month = oct,
  doi = {10.3390/cancers18213449},
  url = {https://www.mdpi.com/2072-6694/18/21/3449},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Interpreting the Early Cancer Peak in Immune-Mediated Inflammatory Diseases. Comment on Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 1027
AU  - Alper Gumustepe
AU  - Esra Gumustepe
PY  - 2026
DA  - 2026/10/26
JO  - Cancers
DO  - 10.3390/cancers18213449
UR  - https://www.mdpi.com/2072-6694/18/21/3449
SN  - 2072-6694
ER  -

Related

Cite